MWP
ALXN

MYCIO Wealth Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

MYCIO Wealth Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-41
Closed -$5K – 740
2016
Q3 		$5K Buy
41
+25
+156% +$3.22K ﹤0.01% 672
2016
Q2 		$2K Buy
+16
New +$2.27K ﹤0.01% 931
2016
Q1 		– Sell
-150
Closed -$29K – 921
2015
Q4 		$29K Hold
150
– – 0.01% 363
2015
Q3 		$23K Hold
150
– – ﹤0.01% 424
2015
Q2 		$27K Hold
150
– – 0.01% 388
2015
Q1 		$26K Hold
150
– – 0.01% 371
2014
Q4 		$28K Hold
150
– – 0.01% 352
2014
Q3 		$25K Sell
150
-100
-40% -$16.4K 0.01% 337
2014
Q2 		$39K Hold
250
– – 0.01% 295
2014
Q1 		$38K Buy
+250
New +$39.8K 0.01% 286

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return